This HTML5 document contains 150 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1038/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q98205283
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu n'agostu de 2020 article scientifique publié en 2020 наукова стаття, опублікована 4 серпня 2020 scientific article published on 04 August 2020 wetenschappelijk artikel
p:P577
wds:Q98205283-C6C035EF-5960-424A-B893-B6CA239B9B83
wdt:P577
2020-08-04T00:00:00Z
p:P2860
wds:Q98205283-E8FAFB51-3FDA-42A3-A789-F8247B6684FC wds:Q98205283-E6827B3A-B0DF-4DAF-89B2-58846E4F53DF wds:Q98205283-F503CE06-C106-4F59-8E86-09D5F398BF2F wds:Q98205283-F1F798CE-DBA1-4216-B32C-C9D3AD3B90F5 wds:Q98205283-F54E7694-4CEA-4FF0-A814-93851503F9D4 wds:Q98205283-F844E865-2777-417F-AD2A-86FFEC591910 wds:Q98205283-F7A883F3-1CBE-4860-AF8B-A254FA9663B4 wds:Q98205283-8FF9821C-BA72-49B5-9452-41C10D1F1053 wds:Q98205283-A0593BC6-C2EF-4147-9760-BDE4039A8269 wds:Q98205283-9A1BE3DD-5842-48EB-B673-2F699E302614 wds:Q98205283-AC57178D-C5B1-4847-8E1F-43AFA6A379AC wds:Q98205283-A64BD03F-C2BE-49D4-8CCE-E546C0ED1691 wds:Q98205283-14D186AE-DD65-4EC7-808B-B8D1358D1ABE wds:Q98205283-13AE02A9-BA67-496B-8BCB-8D7695DEA559 wds:Q98205283-AE4021FB-3077-4588-B063-AEF3DF3C63A2 wds:Q98205283-1C393820-E81B-4CB1-9A41-B2F0FDF8BF30 wds:Q98205283-7005A184-9712-4D9B-A70C-7646C1A1C1F4 wds:Q98205283-6A685D63-AE29-494A-BC9E-A8BC0899E412 wds:Q98205283-23F736A8-B441-46DC-AC62-DDCF4A0B135D wds:Q98205283-72377A87-B1FF-40F5-BD2C-98F7D33EC0C1 wds:Q98205283-7198BE39-23B5-4477-9581-E3A9D8AF40B4 wds:Q98205283-D52D6F50-FF7C-4EC7-8CA5-2AB12BFADA81 wds:Q98205283-D526FB3A-2635-4B5A-A812-156A4BED56D6 wds:Q98205283-0894B8FC-A828-429C-88A1-615785CB8EC0 wds:Q98205283-134172AB-1B8B-4CF5-A30F-E803158DC95D wds:Q98205283-DA2FF440-5D4B-4A9A-AF59-1EEC4FD701C9 wds:Q98205283-0F7DEC74-8864-40DC-80F1-E88561CB4190 wds:Q98205283-E42A015D-FEFB-43DD-B1A0-6D74C6AB6E2C wds:Q98205283-4D61E26F-F9DC-42C2-9E35-85B6856BDD95 wds:Q98205283-57C8F400-427D-4BEF-83B5-E8369F68661B wds:Q98205283-52CD49D5-80F3-482B-9F39-93006A238D97 wds:Q98205283-5A106C3B-0102-4A0F-9CB9-71F8D067064E wds:Q98205283-C06133EB-E63D-4444-AD49-AAE369FE5062 wds:Q98205283-58E2CE2A-079C-4194-A68F-D29411EA0747 wds:Q98205283-B6807033-121B-486B-94FB-928988038350 wds:Q98205283-CD173CE3-6EE4-4342-B81E-A137E35A0FEB wds:Q98205283-5B848EC4-3DA2-45AF-BB04-465DAD9D9B57 wds:Q98205283-347E3D40-F6F7-411F-BB44-B39A3D6551CB wds:Q98205283-CEEB4485-0881-41EA-8A66-7314E0992181 wds:Q98205283-323B97E2-0422-426C-B2DC-9CB1E5E452B5 wds:Q98205283-45A40F1E-D33E-4F48-A8FA-5B648DC1ECC9 wds:Q98205283-473920B2-7308-4906-A674-FF602E35FAB9 wds:Q98205283-4662A5B9-6FDB-4096-9AE0-BF43E260B67D wds:Q98205283-4BB2870C-A957-4989-937F-9395365B0E56 wds:Q98205283-47BCEAA3-856B-4A2A-B87D-638228FC1252
wdt:P2860
wd:Q38641704 wd:Q38103645 wd:Q88717098 wd:Q38992833 wd:Q38264774 wd:Q51786868 wd:Q48085574 wd:Q37296134 wd:Q41031423 wd:Q40788902 wd:Q90590362 wd:Q50773044 wd:Q38079288 wd:Q52906615 wd:Q35545757 wd:Q37400956 wd:Q36057916 wd:Q38146503 wd:Q74554621 wd:Q91861178 wd:Q40675515 wd:Q91215493 wd:Q81374145 wd:Q57801274 wd:Q91330596 wd:Q33437770 wd:Q38673606 wd:Q47578405 wd:Q87082009 wd:Q41441817 wd:Q51118010 wd:Q90028964 wd:Q46083195 wd:Q77437408 wd:Q90028958 wd:Q38635027 wd:Q38659533 wd:Q46660489 wd:Q34488796 wd:Q38641725 wd:Q49029195 wd:Q43690737 wd:Q92179570 wd:Q38647682 wd:Q91991543
rdfs:label
The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG
skos:prefLabel
The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG
schema:name
The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG
p:P50
wds:Q98205283-2A1FD9F3-3CEA-4EC0-9C62-DA225F781CA1 wds:Q98205283-1FB3BC32-08A3-4853-80E1-63638574D298 wds:Q98205283-F714063B-5DEE-4B50-83AB-4B056611B9A3 wds:Q98205283-B1E95F11-50F6-4511-8627-DEB3C6319EEE wds:Q98205283-B17CDB05-EAE3-411D-A019-F1C58E860D6F wds:Q98205283-D8E03723-8749-408E-BAD3-B9A1A524DA0B wds:Q98205283-E10B7921-A537-4480-9695-F694FAE2C314 wds:Q98205283-D6C3C5D5-226F-4EF6-9E6D-E1EA5FA1F926 wds:Q98205283-77316454-A390-46C7-A9BA-5FE08F5F5A08 wds:Q98205283-7A4B6165-C29F-4A6E-AFE4-2BDA09CCF282 wds:Q98205283-AE66CEC0-7C23-42F8-88AE-4F4D3D1C7EFC wds:Q98205283-80DF451C-AD35-4CB6-8F09-6C51B0F59D4A wds:Q98205283-3F1D9807-3DBF-4C5A-BCEE-B9CA5D304243 wds:Q98205283-5CB2D661-82BD-4A56-93A4-65345C440E32 wds:Q98205283-4FA2A2C0-881B-4851-91DE-20514E4EE5C1 wds:Q98205283-266035B4-2B7F-4DE4-827A-C2771AB49AF6 wds:Q98205283-2B0E698E-4012-49AD-A2EF-C54716C3FD2F
wdt:P50
wd:Q54374312 wd:Q95172436 wd:Q89505908 wd:Q98205281 wd:Q98205282 wd:Q114399000 wd:Q56912954 wd:Q116774453 wd:Q100532598 wd:Q83558957 wd:Q85886547 wd:Q77087119 wd:Q116774454 wd:Q91812490 wd:Q91215490 wd:Q63933273 wd:Q90590340
p:P1476
wds:Q98205283-FC49ADA8-3A53-4344-BD1A-7182D6B8F1F2
wdt:P1476
The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG
p:P31
wds:Q98205283-CEB79C07-3B23-456A-8216-7ABA60092595
wdt:P31
wd:Q13442814
p:P698
wds:Q98205283-7A216D05-3718-414F-BF9E-CA4529D079FB
wdtn:P698
n11:32753706
wdt:P698
32753706
p:P1433
wds:Q98205283-7B69D9A0-142A-4916-9B9E-46F4F5D6EF72
wdt:P1433
wd:Q4941523
p:P356
wds:Q98205283-D70787AD-1D59-441D-BA90-80618B54F870
wdtn:P356
n12:S41409-020-01014-X
wdt:P356
10.1038/S41409-020-01014-X